Clinical outcomes, virological efficacy and safety of nitazoxanide in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials.
Tzu-Chieh WengTeng-Song WengChih-Cheng LaiChien-Ming ChaoJui-Hsiang WangPublished in: Expert review of anti-infective therapy (2022)
Although nitazoxanide can help virological eradication and is also tolerable, it does not provide additional clinical benefits. Based on these evidences, the use of nitazoxanide in the treatment of patients with COVID-19 is not recommended.